Efficacy and safety of Niaoqingshu granules in the treatment of chronic pelvic pain syndrome(syndrome of dampness-heat diffusing downward)

Phase 4

Completed

• Conditions: chronic pelvic pain syndrome(syndrome of dampness-heat diffusing downward)

• Registration Number: ITMCTR2200005579
• Lead Sponsor: The First Affiliated Hospital of Tianjin University of Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Completed
• Sex: Male
• Target Recruitment: Not specified

Inclusion Criteria

1) Meet the western diagnostic criteria of non-bacterial CP and TCM syndrome differentiation criteria of dampness-heat syndrome;
2) 18 to 50 years old;
3) The course of disease is not less than 3 months;
4) No prostatitis drugs were used in nearly 2 weeks before inclusion;
5) Informed consent, voluntary subjects;
6) The process of obtaining informed consent conforms to the drug clinical trial Management Code (GCP).

Exclusion Criteria

? Renal function and liver function indexes are above 50% of the upper limit of normal value;
? Patients with serious primary diseases, including lung diseases, hematological diseases and cardiovascular diseases, or AIDS and tumors;
? Have a history of pelvic surgery, severe neurosis, seminal vesiculitis, prostate tumor, benign prostatic hyperplasia, epididymitis, urinary tract diseases and diabetes, etc.
(4) mentally ill or disabled;
? Allergic to the test drug or allergic constitution;
? By non-prostatitis caused by lumbosacral, perineum and lower abdomen and other painful diseases;
? Bacterial CP and acute prostatitis;
(8) those who have or are suspected of drug or alcohol abuse;
? Applicants who are participating in other clinical trials.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
odynuria;pollakisurie;Harnzwang;